Global Statistics Representing Veterinary Pharmaceutical Drugs Market Scenario
Veterinary pharmaceutical drugs are categorized into feed additives, vaccines, tablets and boluses, capsules, oral pastes and gels, drenches and tubing products, and topical dosage forms. These products are manufactured for various categories of animals including cattle, livestock, companion, and other animals. Growing number of favorable government regulations for animal health and welfare and increased consumption of pork and beef meat across the globe, are vital factors driving the global veterinary pharmaceutical drugs market.
Demand for dairy products is increasing year by year with rising population, which has ultimately escalated the demand for veterinary pharmaceutical drugs across the globe. Administering antibiotics to the poultry animals to keep them disease free is the common practice worldwide. According to the NATIONAL CHICKEN COUNCIL, in 2018, there were about 180 slaughter/evisceration plants for broiler chicken, which used more than 60 million tons of mixed feed. The U.S., being one of the leading broiler exporters across the globe, accounts for major share of the global veterinary pharmaceutical drugs market. Global 123 million tons of poultry production in 2018 demanded for high amount of veterinary pharmaceutical drugs, supporting the market growth.
The current global population is 7.7 billion and it is projected to reach 9.8 billion by 2050. The growing population will increase the demand for food, including meat, milk, eggs, and fish. Poultry is one of the fastest-growing agricultural sub-sectors and is likely to continue growing at a healthy CAGR. For instance, in 2018, the combined value of production from broilers, eggs, turkeys, and chickens was accounted for approximately USD 46.3 billion, up by 8% from USD 42.7 billion in 2017 in the U.S., the United States Department of Agriculture (USDA).
The global veterinary pharmaceutical drug market was valued at USD 23,539 million in 2018 and is expected to grow at a CAGR of 5.5% during the forecast period, 2019–2026.
Global veterinary pharmaceutical drugs market is segmented by disease, drug types, sales channel, and region.
Based on disease, the market is segmented into swine influenza, osteoarthritis, Newcastle disease, mastitis, and others. Swine influenza is a highly contagious viral infection in pigs. As of now, three subtypes of influenza A virus have been witnessed, namely A(H1N1), A(H1N2), and A(H3N2). It is dominant in North and South America, Europe and some parts of Asia and Africa. Disease outbreak influences industry growth, making swine influenza highest share grossing segment among disease. Osteoarthritis is a degenerative condition of the joints causing the joint to break down. As per Animal Friends Insurance research, Arthritis can cost pet owners around USD 3,293 a year. Newcastle disease (ND) is highly contagious and affects birds including poultry worldwide, especially in Africa, Asia, and South America. The major concern of Newcastle disease outbreak is its potential economic impact on the poultry industry. However, since wild birds can, sometimes, carry the virus without becoming ill, outbreaks can occur anywhere that poultry is raised. In California, its outbreak began in late 2002 and lasted until 2003. Foot and mouth disease (FMD), rabies, and other disease outbreaks impact biosecurity. This needs proper guidelines to prevent them from spreading further. Rabies is a preventable disease and is mostly found in raccoons, dogs, foxes, and other wild animals. Rabies infection causes thousands of human deaths every year.
Based on drug types, the market is segmented into swine drug, cattle/ruminant drug, poultry drug, horse drug, pets (cats, dogs) drug, and other drug types. Pets drug/companion animal drug segment, accounts for highest share among drug types.
Based on sales channel, the market is segmented into direct sales channel and indirect sales channel. In markets where manufacturers do not have direct commercial presence, offer products through distributors. Most of the companies in such regions offer their livestock and companion animal products through veterinarian. Apart from this, they provide products through local agricultural and farming retail outlets, pharmacies, and pet stores. For instance, Zoetis sells its products to veterinarians, third-party veterinary distributors, and retail outlets that then typically sell the products to livestock producers, making indirect sales channel segment highest share grosser among sales channel. The veterinary drug market is primarily driven by indirect sales, but in few cases, a direct sales channel is involved. For instance, Zoetis sells its livestock products directly to a wide range of livestock producers, including beef and dairy farmers, poultry and pork via distributors. Elanco is planning to expand its retail channels to meet the pet owner's demands.
Regionally, the global veterinary pharmaceutical drugs market is segmented into North America, Europe, Asia-Pacific, South America, Middle East and Africa.
North America dominates the global veterinary pharmaceutical drugs market. High number of companion animals, stringent government regulations regarding the health and safety of companion animals, and frequent outbreak of several animal diseases in the U.S., are some of the vital factors driving North America veterinary pharmaceutical drugs market. According to the American Society for the Prevention of Cruelty to Animals, around 6.5 million companion animals are registered and admitted to the U.S. animal shelters every year, out of which about 3.2 million are cats and 3.3 million are dogs. Moreover, after 2011, the companion animal adoption has increased significantly.
Europe accounts for optimum share of the global veterinary pharmaceutical drugs market.
Asia Pacific is expected to register fastest growth in the veterinary pharmaceutical drugs market. The region is housing a large population of cattle and a significant amount of people generates revenue from the meat of cattle, swine, and other animals. In addition, several governments in the region have imposed stringent regulations for the proper vaccination of the animals, which further drives the Asia Pacific veterinary pharmaceutical drug market. Rapidly expanding industry is expected to boost the demand for veterinary pharmaceutical drugs, fueling market growth. With increasing cattle breeding, market for veterinary pharmaceutical drugs in India is significantly growing.
South America accounts for significant share of the global market owing to the increasing poultry business.
The Middle East veterinary pharmaceutical drug market is holding a relatively low share of the global market. People in the Middle East rely on cattle and livestock animals except swine as their food source. Increasing consumption of beef, mutton, and chicken is expected to increase the demand for veterinary pharmaceutical drugs for obtaining disease-free meat through proper vaccination. Increasing awareness regarding animal health and rising incidences of animal disease outbreaks across the Middle East are expected to fuel the market growth.
Africa is expected to account for least share of the global veterinary pharmaceutical drugs market.
Some of the major players in the veterinary pharmaceutical drugs market are, Boehringer Ingelheim International GmbH, Zoetis, Bayer AG, Elanco, Merck & Co. Inc., Virbac, Dechra Veterniary Products, Ceva, Vetoquinol India Animal Health Pvt. Ltd., Meiji Holdings Co., Ltd., Ourofino Saude Animal, Animalcare Group plc, and Parnell.
Veterinary Pharmaceutical Drugs Market Segmentation
By Drug Type
By Sales Channel
Frequently Asked Questions (FAQs)